The document discusses depression and aims to find new treatments. It hypothesizes that the human brain mineralocorticoid receptor (MR), which binds cortisol, is crucial for behavior during stress and the hormonal stress response. Dysfunction of the MR may lead to vulnerability for depression and anxiety, so the researchers propose the MR as a new drug target for treating depression and anxiety disorders.